Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants.
Eur J Haematol. 2019 Mar 29;:
Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML.
Eur J Haematol. 2019 Apr;102(4):368-374
Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability.
Biol Blood Marrow Transplant. 2019 Jan 14;:
Incidence and Risk Factors for Nontuberculous Mycobacterial Infection after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant. 2018 02;24(2):366-372
Reduced Intensity Conditioning and Dual T-Lymphocyte Suppression with Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide as Graft Versus Host Disease Prophylaxis In Haploidentical Stem Cell Transplants For Hematological Malignancies.
Biol Blood Marrow Transplant. 2018 Jul 12;:
Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies.
Ann Hematol. 2018 Jun 11;:
Efficacy of Cidofovir in Treatment of BK Virus-Induced Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplant Recipients.
Biol Blood Marrow Transplant. 2018 Apr 18;:
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant.
Eur Respir J. 2018 May;51(5):
Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.
Bone Marrow Transplant. 2018 Mar;53(3):361-365
Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
Bone Marrow Transplant. 2018 Mar;53(3):334-338